#USA #MedTech #Houston #ProximaCRO #Eric Ross

Proxima Clinical Research Welcomes Eric Ross as New CEO

In a significant strategic move, Proxima Clinical Research has announced the acquisition of the company, with industry expert Eric Ross stepping in as the new Chief Executive Officer. This change is set against the backdrop of Houston's burgeoning MedTech ecosystem, where Proxima has positioned itself as a frontrunner in supporting both medical technology and biotechnology enterprises.

A New Leadership Era

The transition, publicly revealed by Billy Howell, the Chairman of the Board, marks a pivotal moment for Proxima, which has established itself as a dedicated contract research organization (CRO) within the MedTech industry. Eric Ross brings with him a wealth of experience, having undertaken various leadership roles within both contract research and eClinical organizations. His extensive background makes him well-equipped to drive Proxima’s mission of enhancing healthcare innovation and regulatory success.

"I am honored to join the Proxima team during this significant period of change in the industry," commented Ross upon his appointment. He emphasized the importance of Proxima's regulatory team, attributing their expertise as foundational to the clinical success of MedTech innovations. Furthermore, he acknowledged Proxima's reputation as the preferred CRO for AI-focused MedTech companies, reflecting their commitment to navigating regulatory hurdles and facilitating product approvals.

Enhancing Collaboration and Growth

Billy Howell's excitement over the acquisition reflects a robust vision for the Houston community. He noted that Proxima's dedication to fostering innovative MedTech aligns perfectly with broader initiatives to create a vibrant healthcare ecosystem in Texas. Howell’s ownership of HGI Clinical, another CRO specializing in early-phase oncology and gene therapy, is expected to create synergies that will propel entrepreneurial ventures within the MedTech sector. This collaboration strategy exemplifies a forward-thinking approach that aims to expedite medical advancements and clinical trials.

Eric Ross elaborated on his vision, stating, "I look forward to working closely with the talented team at Proxima to accelerate our customers' path to approval and bring additional MedTech and biotech solutions to patients." His leadership is seen as a catalyst for enhancing service delivery and operational efficiency, which are critical components in an increasingly competitive industry.

About Proxima Clinical Research

Founded in 2017 and headquartered in the heart of Houston's Texas Medical Center, Proxima is a CRO that specializes in providing regulatory, quality, and clinical research expertise for diverse life sciences industries. With a footprint that spans 18 countries across five continents, Proxima is well-positioned to collaborate with stakeholders in medical devices, pharmaceuticals, biotechnology, and diagnostics.

In a rapidly evolving landscape where innovation in medical science is paramount, Proxima's strategic initiatives under Eric Ross's leadership are poised to contribute significantly to improved patient outcomes. To stay updated about Proxima and its ongoing projects, visit ProximaCRO.com.